JPRN-UMIN000044022Recruiting未知
Prospective research for biomarkers for early detection of immune-related adverse events attributed to immune checkpoint inhibitors - Research for irAE biomarkers
Hokkaido University of Science Faculty of Pharmaceutical Sciences0 sites25 target enrollmentStarted: April 23, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 25
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Doctor has determined who are not suitable for research
Investigators
Similar Trials
Completed
Not Applicable
Can biomarkers be used to improve patient selection and overall survival in patients starting immunotherapy treatment for non-small cell lung cancer (NSCLC) and genitourinary cancersBladder canceron-small cell lung cancerKidney CancerCancer - Lung - Non small cellCancer - BladderCancer - KidneyNon-small cell lung cancerACTRN12620000090910Ingham Institute for Applied Medical Research48
Completed
Not Applicable
Prospective research of the biomarkers associated with adjuvant chemotherapy in patients with resectable biliary tract cancerBiliary tract cancerJPRN-UMIN000004613Department of Medical Oncology, University of Miyazaki Hospital50
Completed
Not Applicable
Research for new biomarker about diagnosis and evaluation of disease condition for inflammatory bowel disease (IBD).Inflammatory bowel diseaseJPRN-UMIN000017831Kyoto Prefectural University of Medicine400
Completed
Not Applicable
Prospective study for predictive biomarkers and modified risk scoring model for venous thromboembolism in Japanese patients with unresectable or metastatic cancer.lung cancer, esophageal cancer, gastric cancer, biliary tract cancer, pancreatic cancer, colorectal cancerJPRN-UMIN000026826Clinical Research Center, Saga University Hospital240
Recruiting
Not Applicable
A clinical study to identify biomarkers for determining the malignant potential of ovarian immature teratomaovarian cancerJPRN-UMIN000046404HO Kyoto Medical Center200